We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

51 hedge funds and large institutions have $149M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

4% more capital invested

Capital invested by funds: $142M → $149M (+$6.21M)

2% less funds holding

Funds holding: 52 → 51 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
51
Holders Change
-1
Holders Change %
-1.92%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$3.81M
2
Jane Street
Jane Street
New York
+$3.69M
3
AC
Aristeia Capital
Connecticut
+$1.52M
4
FTCM
First Trust Capital Management
Illinois
+$901K
5
Millennium Management
Millennium Management
New York
+$675K

Top Sellers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
-$3.86M
2
UOC
UBS O'Connor
Illinois
-$2.34M
3
CCM
Context Capital Management
California
-$1.04M
4
CF
Cantor Fitzgerald
New York
-$999K
5
AFM
Anson Funds Management
Texas
-$738K
Name Holding Trade Value Shares
Change 		Change in
Stake
6CM
1
683 Capital Management
New York
$12M – – –
FTCM
2
Fir Tree Capital Management
New York
$9.62M -$329 -33 -0%
GCL
3
Glazer Capital LLC
New York
$8.32M +$3.81M +382,235 +86%
KL
4
KIM LLC
Kansas
$8.06M – – –
MI
5
MMCAP International
Cayman Islands
$8.04M – – –
HSBC Holdings
6
HSBC Holdings
United Kingdom
$7.07M +$426K +42,801 +7%
CSS
7
Cubist Systematic Strategies
Connecticut
$6.32M -$49.8K -5,004 -0.8%
Millennium Management
8
Millennium Management
New York
$6.29M +$675K +67,821 +12%
CF
9
Cantor Fitzgerald
New York
$5.92M -$999K -100,300 -15%
MF
10
Magnetar Financial
Illinois
$5.17M – – –
ACM
11
Atalaya Capital Management
New York
$5.04M – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
12
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$5.04M – – –
PSAMP
13
P. Schoenfeld Asset Management (PSAM)
New York
$5.03M – – –
PC
14
Periscope Capital
Ontario, Canada
$4.74M +$2.99K +300 +0.1%
RCM
15
Radcliffe Capital Management
Pennsylvania
$4.14M +$5.88K +591 +0.1%
AC
16
Aristeia Capital
Connecticut
$4.05M +$1.52M +152,900 +61%
Calamos Advisors
17
Calamos Advisors
Illinois
$3.78M – – –
Jane Street
18
Jane Street
New York
$3.73M +$3.69M +370,967 New
AGC
19
Angelo Gordon & Co
New York
$3.02M – – –
Marshall Wace
20
Marshall Wace
United Kingdom
$2.97M – – –
FTCM
21
First Trust Capital Management
Illinois
$2.67M +$901K +90,500 +52%
SC
22
Sculptor Capital
New York
$2.51M – – –
SCM
23
Shaolin Capital Management
Florida
$2.48M +$249K +25,000 +11%
AA
24
AQR Arbitrage
Connecticut
$2.01M – – –
TCA
25
Taconic Capital Advisors
New York
$1.97M – – –
1
2 3

ORIA Hedge Fund Activity: Q4 2022 in Review

51 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q4 2022, worth a combined $149M — up 4.4% from $142M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ORIA and 5 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 11 added.

The largest buyer was Glazer Capital LLC, adding an estimated $3.81M. The largest seller was HighTower Advisors, cutting an estimated $3.86M.

  • 51 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q4 2022, down from 52 in Q3 2022.
  • Funds reported $149M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q4 2022, up 4.4% quarter-over-quarter.
  • 5 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q4 2022 and 6 closed out, a net change of -1 holder.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q4 2022 was Glazer Capital LLC, an estimated $3.81M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q4 2022 was HighTower Advisors, an estimated $3.86M sold.

Based on aggregated 13F filings for Q4 2022.